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Parathyroid Localization 
R. G U T E K U N S T , A. V A L E S K Y , B. B O R I S C H , W. H A F E R M A N N , E . K I F F N E R , 
E . T H I E S , U . L O H R S , A N D P. C. S C R I B A 
Departments of Internal Medicine (R.G., W.H., P.C.S.) and Surgery (A.V., E.K., E.T.), Institutes of 
Anatomy (B.B.) and Pathology (U.L.), Medical University Lübeck, Lübeck, West Germany 
A B S T R A C T . Twenty-nine consecutive patients with sus-
pected primary hyperparathyroidism were examined preopera-
tively using ultrasound, sonographically guided fine needle as-
piration, and aspirate immunostaining for PTH. In 25 patients, 
localization of enlarged parathyroid glands was successful. In 2 
patients, the tumors were located retrosternal^ and, thus, could 
not be detected by ultrasound. One patient had a multinodular 
goiter which impeded localization. In 1 patient with renal osteo-
dystrophy, 2 enlarged parathyroid glands in the neck were not 
visualized preoperatively. Cytology was not diagnostic, although 
some cytological features were suggestive of parathyroid cells. 
Immunostaining of the aspirated smears for PTH, however, 
correctly diagnosed all preoperatively localized lesions. Ultra-
sound should be the routine procedure of choice for preoperative 
localization of abnormal parathyroid glands in primary hyper-
parathyroidism. Fine needle aspiration and immunocytochem-
istry can supply confirmation, if necessary. {J Clin Endocrinol 
Metab 63: 1390, 1986) 
PR E O P E R A T I V E localization of abnormal parathy-roid glands in patients with primary hyperparathy-
roidism (pHPT) is still a challenge. Preoperative detec-
tion of abnormal parathyroid glands by ultrasound has 
been reported by many groups (1, 2, 4-7), and some have 
combined sonographic localization with sonographically 
guided fine needle aspiration (FNA) (3, 8). These aspi-
rates have been examined cytologically and immuno-
stained for P T H in attempts to make a morphological 
diagnosis. We combined ultrasound, sonographically 
guided FNA, cytology, and immunocytochemical P T H 
staining for preoperative detection of enlarged parathy-
roid glands. 
Materials and Methods 
All patients (n = 29; 19 women and 10 men; age, 17-80 yr; 
mean age, 52 yr) who underwent parathyroid surgery between 
January 1983 until December 1985 with a diagnosis of p H P T 
were preoperatively evaluated for localization of the glands. 
The diagnosis of p H P T was based on serum calcium and P T H 
determinations (9). All patients were operated for p H P T for 
the first time, although 2 patients had previous surgery for 
nodular goiter. One patient had renal osteodystrophy. 
The thyroid and neck were examined by ultrasound ( S R T , 
linear MHz 5, General Electric, Rancho Cordova, CA). Sonol-
ucent and echocomplex nodules outside the thyroid capsule 
were biopsied under sonographic guidance with a fine needle 
(od, 0.6-0.7 mm). In one patient, a suspicious sonolucent nodule 
Received March 27, 1986. 
Address requests for reprints to: Dr. R. Gutekunst, Klinik für Innere 
Medizin, Medical University Lübeck, Ratzeburger Allee 160, 2400 
Lübeck, West Germany. 
was seen within the thyroid and was aspirated. This patient 
had previously undergone bilateral subtotal thyroidectomy for 
nodular goiter. In all patients, biopsies from one or two areas 
(Table 1) were performed. In only a few patients was a second 
pass, to obtain sufficient material, necessary. Patients with 
coexisting nodular goiter were biopsied additionally a maximum 
of four times at sites that were nodular but not considered 
typical for parathyroid adenoma. The smears were air dried. 
Half were stained by the May-Grünwald-Giemsa technique for 
morphological evaluation. The other specimens were immuno-
stained for P T H by a modification of the peroxidase-antiper-
oxidase technique described by Sternberger (10). A chicken C -
terminal antihuman PTH-(44-65) antibody ( I B L Co., Ham-
burg, West Germany) diluted 1:50 was applied and incubated 
for 9 h at 37 C. Antichicken immunoglobulin G antiserum 
conjugated with rabbit peroxidase (Medac Co., Hamburg, West 
Germany) diluted 1:25 was added, and incubation was carried 
out for 30 min at room temperature. To visualize the peroxidase 
reaction, staining was completed with 3,3'-diaminobenzidine 
solution (0.03% plus 0.03% H 2 0 2 ) for 5 min. At these dilutions, 
the antisera did not cross-react with fresh postmortem cytolog-
ical specimens obtained from liver, thyroid, and kidney. 
Results 
The decision for surgery was based on clinical and 
biochemical grounds alone. All patients who had a pre-
operative diagnosis of pHPT, based on the presence of 
hypercalcemia (range, 2.7-4.0 mmol/liter; mean, 3.3; up-
per limit of normal, 2.7) and an inappropriately high 
serum P T H concentration (range, 300-30,000 ng/ml; 
upper limit of normal, 200) proved to have a parathyroid 
adenoma or primary parathyroid gland hyperplasia on 
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T A B L E 1. Clinical characteristics of patients with pHPT and maximal 
















1 47 F 1,335 3.2 L L 2.5 
2 51 F 300 3.0 LL, LR 2.8, 2.1 
3 36 F 364 3.6 UL 2.0 
4 64 F 1,908 2.7 T 2.3 
5 54 M 6,140 3.9 L L 4.2 
6 17 M 1,229 3.1 LR 3.8 
7 36 F 840 3.5 L L 5.2 
8 27 F 1,820 2.8 L L 1.9 
9 38 F 616 4.0 UL 2.8 
10 76 F 300 3.3 UL 3.7 
11 72 M 380 3.2 UR 2.2 
12 80 M 1,000 2.8 UL 4.6 
13 46 F 716 3.7 L L 3.8 
14 22 M 311 3.2 LL, UR 2.9, 2.2 
15 38 M 346 3.1 L L 1.9 
16 47 F 30,000 2.9 UL 2.7 
17 25 F 346 4.0 LR 4.1 
18 76 M 1,029 3.1 L L 1.1 
19 71 F 832 3.1 UR 2.8 
20 52 M 458 3.2 L L 3.7 
21 68 F 802 3.6 L L 1.3 
22 70 F 1,442 3.1 L L 5.3 
23 36 M 927 2.8 UR 1.8 
24 75 F 456 3.0 L L 4.1 
25 53 F 720 3.5 LR 3.8 
26° 43 F 1,500 4.0 R 3.2 
27° 52 F 3,500 2.7 UL 7.8 
28° 74 F 752 2.9 R 3.6 
29° 68 M 1,853 3.3 UL, UR 1.6, 1.8 
Normal range <200 <2.7 
R, Retrosternally; T, intrathyroidal; LL, lower left lobe; UL, upper 
left lobe; LR, lower right lobe; UR, upper right lobe. 
° Adenomas, not localized sonographically. 
histological examination (the maximal diameter of the 
surgical specimens ranged from 1.1-5.3 cm). Pertinent 
clinical data are illustrated in Table 1. In 23 patients 
solitary adenomas and in 2 patients (patients 2 and 14) 
2 enlarged parathyroid glands were identified preopera-
tively. Subsequent surgical findings agreed with the pre-
operative ultrasonographic localization and the approx-
imate predicted dimensions (Fig. 1). In 4 patients, ab-
normal parathyroid glands were not located preopera-
tively. Two of these patients had adenomas that were 
retrosternal and, thus, not accessible to ultrasonographic 
detection (patients 26 and 28). In the third patient (no. 
27), detection of abnormal parathyroid tissue was not 
possible due to the presence of multiple sonolucent nod-
ules in a goiter; this patient had 1 adenoma. The fourth 
patient (no. 29) had renal osteodystrophy, and 2 enlarged 
hyperplastic parathyroid glands were found at the time 
of surgical exploration. 
Definite cytological discrimination between thyroid 
and parathyroid cells was not possible. Lymphocytes and 
cells from other tissues of nonthyroid origin, however, 
could be identified. Some cytological features were 
suggestive of parathyroid cells. Thus, parathyroid cells 
have lighter, often foamy and more narrow cytoplasm, 
and their nuclei are larger and more marginally situated 
compared to thyroid cells (Fig. 2). 
Positive P T H immunostaining was seen in cells from 
all aspirates (Fig. 3). In one patient in whom a parathy-
roid adenoma was located within the thyroid gland, cy-
tology was not diagnostic, but the aspirate stained with 
ant i -PTH. Thus, immunocytochemistry made the cor-
rect preoperative diagnosis in this patient. 
After transient postoperative calcium replacement 
therapy, serum calcium and P T H concentrations re-
turned to normal levels in all patients. 
Discussion 
Preoperative localization of abnormal parathyroid 
glands has been attempted by various invasive and non-
invasive procedures. Selective angiography and venous 
catheterization with determination of serum P T H con-
centrations are invasive and technically difficult (11). 
Imaging procedures employing subtraction scanning with 
2 1 0~thallium and ""technetium have been successfully 
employed, but further experience with these techniques 
is necessary (12). Computerized tomography is costly 
and has a relatively low yield (13, 14). Ultrasonographic 
localization has been reported by various researchers to 
be useful (1, 2, 4-7), and attempts to improve its speci-
ficity by F N A have been made. However, the ability of 
cytologists to differentiate between thyroid and parathy-
roid cells is questionable (15, 16). Other groups have 
assayed the biopsy material for P T H content, with useful 
results (3, 17). P T H immunostaining, however, relates 
the P T H to the cells. A comparison of R I A and immuno-
staining with regard to sensitivity and specifity is needed. 
Our results demonstrate that preoperative ultrasono-
graphic localization is a safe, noninvasive, inexpensive, 
and reliable method for the detection of enlarged para-
thyroid glands located in the neck. Due to the limitation 
of the method, one cannot detect intrathoracic tumors. 
Sonography has further limitations in patients who have 
large multinodular goiters. The smaller the parathyroid 
gland, the more difficulties will arise in locating it. There-
fore, hyperplastic parathyroids in patients with chronic 
renal failure are often difficult to detect (7). Despite the 
fact that the resolution of ultrasound now reaches ap-
proximately 1 mm, small tumors can be easily missed by 
this method. 
Although the addition of cytology to ultrasound seems 
to be promising, more experience must be obtained con-
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F I G . 1. A, Right transverse sonogram of the thyroid and the typical sonolucent parathyroid adenoma, as indicated in B , in patient 17. B , Schematic 
drawing of the sonogram. TH, Thyroid; C, carotid artery; A, parathyroid adenoma; S, sternocleidomastoid muscle; T, trachea; V, jugular vein. C, 
Surgical specimen of the enlarged parathyroid gland (4 cm) with the lesion (arrow) caused by preoperative F N A . 
F I G . 2. Smear from F N A of a parathyroid 
adenoma (May-Grünwald-Giemsa; orig-
inal magnification, X480). 
P A R A T H Y R O I D L O C A L I Z A T I O N 1393 
F I G . 3. Smear from F N A of parathyroid 
adenoma immunostained for PTH (orig-
inal magnification, X120). The arrows 
indicate PTH immunostaining. 
cerning the details of parathyroid cell morphology. At 
present, the benefit of cytology is to identify the aspirated 
cells as parathyroid and/or thyroid cells. Since immu-
nocytochemistry is gradually becoming a routine proce-
dure, addition of this method may help to establish the 
correct final diagnosis. 
In conclusion, we believe that sonography is the pro-
cedure of choice for preoperative localization of abnormal 
parathyroid glands in patients with p H P T . Immunocy-
tochemistry can supply conformation, if necessary. The 
utility of these procedures for identifying parathyroid 
tissue in patients who had a previously unsuccessful 
operation is not known. 
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pertension, effect of sodium balance 
and calcium channel-blocking drugs 
on, 63:1126 
Angiotensinogen, in human pituitary lacto-
troph cells and PRL-secreting adeno-
mas, 63:231 
Apparent mineralocorticoid excess syndrome, 
association with ll/?-dehydrogenase 
and 5/3-reductase deficiencies, conse-
quences for corticosteroid metabolism, 
63:550 
Arginine vasopressin, in human follicular 
fluid, 63:928 
Aromatase, response to dexamethasone, in 
human skin fibroblasts, 63:468 
Aromatization, by skeletal muscle, 63:717 
Atrial natriuretic peptide 
depressor effects and release of, during nor-
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epinephrine or angiotensin I I infusion, 
63:669 
in umbilical cord blood, 63:1414 
plasma levels 
in patients with chronic renal failure, 
63:819 
in primary aldosteronism and essential 
hypertension, 63:815 
relationship with atrial pressure, 63:823 
renal, hemodynamic, and hormonal re-
sponses to infusions of, effect of so-
dium intake, 63:946 
RIA and characterization in human plasma, 
63:72 
«-Atrial natriuretic polypeptide, human, ef-
fect on aldosteronogenesis in aldoster-
one-producing adenoma, 63:192 
Autoimmune disease, serum from patients 
with, effect on production of disease-
associated antibodies by peripheral 
blood mononuclear cells from normal 
subjects, 63:683 
Autoimmune thyroid disease, thyrocyte HLA-
DR expression and interferon-7 pro-
duction in, 63:695 
Autonomic neuropathy, abnormal cardiac 
function in diabetic patients with, in 
absence of ischemic heart disease, 
63:208 
Bone, histomorphometry, comparison with 
PTH assays, in renal osteodystrophy, 
63:1163 
Bone Gla-protein, serum levels, in renal os-
teodystrophy, 63:892 
8-Bromo-3',5'-adenosine monophosphate, 
stimulation of endocrine activity of hu-
man cytotrophoblasts, 63:1211 
Bromocriptine 
effect on fibrous tissue content of PRL-
secreting and nonfunctioning pituitary 
macroadenomas, 63:383 
GH-lowering effect of, in acromegaly, 
63:16 
hormonal and clinical effects in polycystic 
ovary syndrome, 63:119 
injectable form of, suppression of PRL se-
cretion and rapid shrinkage of prolac-
tinomas by, 63:266 
Buserelin, pharmacokinetic characteristics of, 
in children with central precocious pu-
berty, 63:1065 
Cabergoline, PRL-lowering effect of, in hy-
perprolactinemic patients, 63:941 
Calcitonin 
effect on cytoplasmic spreading of rat os-
teoclasts, 63:1080 
plasma levels, in primary hyperparathy-
roidism, 63:785 
Calcitriol, antiproliferative effect on human 
peripheral blood mononuclear cells, 
63:394 
Calcium 
alterations with aging, in normal men, 
63:1262 
-dependent release of PTH fragments by 
parathyroid tissue, 63:1075 
modulation of prostaglandin E 2 release 
from human gastric mucosal cells, 
63:886 
role in steroidogenesis in fetal adrenal, 
63:913 
serum levels, relation to red cell sodium 
transport, in hypoparathyroidism, 
63:626 
Calcium channel-blocking drug, effect on 
plasma aldosterone response to angio-
tensin I I , in normal subjects and pa-
tients with essential hypertension, 
63:1126 
Calcium-regulating hormone, stimulation of 
creatine kinase activity in human am-
nion, decidua, and placenta by, 
63:1052 
Calmodulin, modulation of prostaglandin E 2 
release from human gastric mucosal 
cells, 63:886 
Calpain, distribution in human pituitary 
gland, 63:343 
Calpastatin, distribution in human pituitary 
gland and selective localization in 
ACTH-producing cells, 63:343 
Cancer, prostatic, serum LH biological activ-
ity in castrated patients with, 63:297 
Carbamazepine, effect on serum dehydroe-
piandrosterone sulfate, in patients 
with seizures with temporal lobe in-
volvement, 63:243 
Carcinoma 
endometrial, effects of estradiol on DNA 
polymerase in, 63:356 
thyroid, long term results of treatment of 
patients with lung and bone metastases 
from, 63:960 
Cardiac function, in diabetic patients with 
autonomic neuropathy, 63:208 
Catecholamine-synthesizing enzyme, ontog-
eny in primate fetal adrenal medulla, 
63:974 
Children 
antidiuretic effect and pharmacokinetics of 
oral l-desamino-8-D-arginine vaso-
pressin in, 63:129 
boys, progressive decrease in serum sex hor-
mone-binding globulin from infancy to 
late prepuberty in, 62:510 
GH responses to GHRH during pubertal 
development, comparison to idiopathic 
short stature and GH deficiency, 
63:174 
girls with pseudoprecocious puberty due to 
autonomous ovarian cysts, adrenal ste-
roid secretion in, 63:828 
girls with true precocious puberty, rapid 
ovarian secretory response to pituitary 
stimulation by nafarelin in, 63:1386 
hypopituitary boys, pubertal growth and 
final height in, role of bone age at onset 
of puberty, 63:376 
with central precocious puberty, pharma-
cokinetic characteristics of buserelin 
in, 63:1065 
with GH neurosecretory dysfunction, pres-
ervation of dopaminergic and a-adre-
nergic function in, 63:968 
with partial GH deficiency, effect of 
GHRH-U-44) on 24-h GH secretion in, 
63:1100 
with the Prader-Willi syndrome, effects of 
naltrexone in, 63:1229 
with uremia, effect of low protein diet on 
glucose metabolism in, 63:985 
Chlorbutol, inhibition of aldosterone biosyn-
thesis, 63:780 
Choriocarcinoma, estrone, 17ß-estradiol, and 
estriol secretion by cells of, effects of 
dehydroepiandrosterone sulfate and 
16«-hydroxydehydroepiandrosterone 
sulfate on, 63:751 
Cirrhosis, feedback inhibition of insulin se-
cretion in, 63:1023 
Clomiphene citrate, plasma estradiol levels 
during stimulation with, 63:736 
Clonidine, suppression test for pheochromo-
cytoma, misleading results, 63:238 
Congenital adrenal hyperplasia 
corticosteroid metabolism in, 63:550 
due to 11 ß-hydroxylase deficiency, require-
ment of mineralocorticoid in, 63:36 
21-hydroxylase deficiency in, late-onset, 
63:418 
3ß-hydroxysteroid dehydrogenase deficiency 
syndrome in, new inherited variant, 
63:360 
Contraception 
intranasal regimens of LHRH agonist com-
bined with oral progestrogen as anti-
ovulatory approach, 63:379 
using a vaginal ring, in hypertensive 
women, 63:29 
Corticotropin-releasing hormone 
ectopic secretion of, Cushing's syndrome 
secondary to, 63:770 
immunoactivity, in maternal and fetal 
plasma during pregnancy, 63:1199 
-induced ACTH secretion in normal sub-
jects and patients with Cushing's dis-
ease, effect of FK 33-824 on, 63:1427 
ovine, prolonged pulsatile administration 
of, 63:1292 
response of ectopic ACTH syndrome 
caused by lung cancer to, 63:1047 
responsiveness of hypophyseal-adrenocor-
tical axis to, in patients with ACTH 
deficiency, 63:329 
Cortisol 
familial resistance to, differential diagnos-
tic and therapeutic aspects, 63:1328 
levels in obese women, 63:1257 
production, in women runners, 63:133 
serum levels, sensitivity and responsivity to 
«ACTH-(l-24), in women, 63:860 
C-Peptide 
biosynthetic human, effect of ingestion of 
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C-Peptide (continued) 
mixed meal on MCR of, 63:401 
venous levels, response to increasing glu-
cose loads, 63:492 
Creatine kinase, activity in human amnion, 
decidua, and placenta, stimulation by 
calcium-regulating hormones, 63:1052 
CRH, See Corticotropin-releasing hormone 
Cushing's disease, effect of FK 33-824 on 
CRH-induced ACTH secretion in pa-
tients with, 63:1427 
Cushing's syndrome 
ketoconazole treatment of, 63:1365 
pituitary-adrenal response to RU 486 in, 
63:639 
secondary to ectopic CRH/ACTH secre-
tion, 63:770 
Cyproterone acetate, effects in polycystic 
ovarian disease, 63:1031 
Cytochrome P450scc, hormonal regulation of, 
in human granulosa cells, 63:202 
Dawn phenomenon, occurence in elderly sub-
jects, 62:292 
Dehydroepiandrosterone sulfate 
effect on estrone, 17ß-estradiol, and estriol 
secretion, in human choriocarcinoma 
cells, 63:751 
serum levels, effect of phenytoin and car-
bamazepine on, in patients with sei-
zures with temporal lobe involvement, 
63:243 
11/i-Dehydrogenase, deficiency, association 
with the apparent mineralocorticoid 
excess syndrome, 63:550 
Deoxyribonucleic acid polymerase a, activity 
in the Ishikawa human endometrial 
adenocarcinoma cell line, effects of es-
tradiol on, 63:356 
l-Desamino-8-D-arginine vasopressin, anti-
diuretic effect and pharmacokinetics 
of, in adults and children, 63:129 
17,20-Desmolase, activity in adrenal cortex, 
regulation of, 63:613 
Dexamethasone 
response of aromatase to, in human skin 
fibroblasts, 63:468 
suppression testing, in chronic renal failure, 
63:741 
Diabetes, hypoinsulinemic, receptor-me-
diated endocytosis of polypeptide hor-
mones in rats and humans with, 
63:151 
Diabetes insipidus, antidiuretic effect and 
pharmacokinetics of oral 1-desamino-
8-D-arginine vasopressin in, 63:129 
Diabetes mellitus 
abnormal cardiac function in patients with 
autonomic neuropathy and, in absence 
of ischemic heart disease, 63:208 
gestational, serum levels of somatomedins 
and somatomedin-binding protein in 
pregnant women with, 63:1300 
insulin-dependent 
antiinsulin receptor antibodies in, 63:56 
decreased ^-adrenergic sensitivity in pa-
tients with, 63:262 
somatostatin analogs and insulin needs 
in patients with, studied by means of 
artificial pancreas, 63:1071 
serum insulin-like growth factor I levels in 
adults with, effect of age, 63:651 
type I 
GHRH-(l-44)-induced GH secretion in, 
effect of cholinergic muscarinic recep-
tor blockade on, 63:389 
pharmacokinetics of sc regular insulin in 
patients with, 63:689 
serum levels of somatomedins and so-
matomedin-binding protein in preg-
nant women with, 63:1300 
with autonomic neuropathy and orthostatic 
hypotension, <v2-adrenergic receptors 
opn platelet membranes from patients 
with, 63:906 
1,25-Dihydroxyvitamin D 
associated with secondary hyperparathy-
roidism and normal osteocalcin, in el-
derly subjects, 63:459 
serum levels, ketoconazole-induced reduc-
tion in, 63:766 
severely deficient binding to receptors, in a 
patient responsive to high doses of 
l,25-(OH)2D, 63:252 
24,25-Dihydroxyvitamin D ; ), effect in primary 
hyperparathyroidism, 63:246 
Dopamine 
antagonist of, LH response to, in hyperpro-
lactinemic women with pituitary mi-
croadenoma, 63:1225 
effects in polycystic ovary syndrome, 
63:506 
inhibition of aldosterone response to up-
right posture, 63:197 
interaction with estradiol on PRL release 
by normal and tumorous pituitary 
cells, 63:1342 
Ectopic adrenocorticotropin syndrome, 
caused by lung cancer, response to 
CRH, 63:1047 
Empty sella, occurrence of in untreated acro-
megaly, 63:287 
Endocytosis of polypeptide hormones, in hy-
poinsulinemic diabetes of rat and man, 
63:151 
Endometriosis, treatment in monkeys, 
63:1277 
Endometrium, lipocortin output by, 63:162 
Enkephalin-synthesizing enzyme, ontogeny 
in primate fetal adrenal medulla, 
63:974 
Enolase, subunits, in patients with neuroen-
docrine tumors, 63:94 
Estradiol 
and hemodynamics during ovulation induc-
tion, 63:721 
effects on DNA polymerase a activity, in 
the Ishikawa human endometrial ad-
enocarcinoma cell line, 63:356 
fraction bound to sex hormone-binding 
globulin, in human follicular fluid, 
63:1106 
free, in human follicular fluid, 63:1106 
in human follicular fluid, 63:1106 
interaction with dopamine on PRL release 
by normal and tumorous pituitary 
cells, 63:1277 
plasma levels, during clomiphene citrate/ 
human menopausal gonadotropin 
stimulation, 63:736 
serum bioavailability and tissue metabo-
lism of, in rat salivary gland, 63:20 
17/i-Estradiol, secretion by human choriocar-
cinoma cells, effects of dehydroepian-
drosterone sulfate and 16«-hydroxy-
dehydroepiandrosterone sulfate on, 
63:751 
Estriol, secretion by human choriocarcinoma 
cells, effects of dehydroepiandroster-
one sulfate and l6a-hydroxydehydro-
epiandrosterone sulfate on, 63:751 
Estrogen 
aromatization in skeletal muscle, 63:717 
neuroendocrine response of LH to 
dependence on hormonal environment 
not sex, 63:589 
in heterosexual, homosexual, and trans-
sexual subjects, 63:583 
replacement in postmenopausal women, ef-
fect on regulation of GH and somato-
medin^ secretion, 63:424 
-responsive neurophysin from human 
plasma, ampholyte displacement and 
high pressure liquid chromatographic 
separation of, 63:835 
Estrogen 16cv-hydroxylase 
activity in human fetal tissues, 63:404 
in human fetal liver, 63:180 
Estrone, secretion by human choriocarcinoma 
cells, effects of dehydroepiandroster-
one sulfate and 16«-hydroxydehydro-
epiandrosterone sulfate on, 63:751 
Fatty acid 
free 
effect on free T 4 serum levels, role of 
albumin, 63:1394 
plasma levels, effect of obesity on, 63:481 
FFA, See Fatty acid, free 
Fibroid tumor, uterine, removal without sur-
gery, 63:619 
FK 33-824, effect of CRH-induced ACTH se-
cretion, in normal subjects and pa-
tients with Cushing's disease, 63:1427 
Follicle-stimulating hormone 
-dependent progesterone production by 
granulosa cells, effect of met-enkeph-
alin on, 63:1222 
ovulation induction with, compared to in-
duction by human menopausal gonad-
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otropin, 63:1284 
ratio of serum bioactive to immunoreactive, 
in normal men after treatment with 
GnRH antagonist, 63:792 
JV-Formyl chemotactic peptide, specific recep-
tors for, on human spermatozoa, 
63:841 
FSH. See Follicle-stimulating hormone 
Galanin, localization and molecular forms of 
in human adrenals, 63:1372 
Gammopathy, monoclonal, in Hashimoto's 
thyroiditis and malignant lymphoma 
of the thyroid, 63:1136 
Gastrointestinal hormone, circulating levels, 
effects of peptide YY on, 63:803 
GH, See Growth hormone 
GHRH, See Growth hormone-releasing hor-
mone 
Glucagon 
metabolic response to, effect of total pan-
createctomy on, 63:433 
plasma levels, effect of obesity on, 63:481 
responses to infusion of, in pseudohypopar-
athyroidism, 63:1354 
Glucose 
forearm uptake of, influence of graded hy-
perglycemia on, 63:594 
hepatic and peripheral metabolism, effect 
of glucose ingestion on, 63:541 
increasing loads of, effects on incretin, 
63:492 
ingestion, effect on hepatic and peripheral 
glucose metabolism, 63:541 
metabolism in children with uremia, effect 
of low protein diet on, 63:985 
plasma levels, effect of obesity on, 63:481 
regulation by T 4 and T 3 , 63:62 
turnover parameters, effect of insulin oscil-
lations on, in normal subjects, 63:520 
utilization, basal and insulin-stimulated, ef-
fects of ketone bodies, 63:9 
GnRH, See Gonadotropin-releasing hormone 
Goiter 
congenital, with thyroglobulin deficiency, 
level of thyroglobulin mRNA in, 
63:931 
endemic 
effect of iodized oil on growth of, 63:644 
thyroid function, in Northern Italy, 63:558 
endemic iodine deficiency, prevention and 
treatment by iodination of water sup-
ply, 63:368 
Gonadotropin 
human chorionic, sensitive and specific as-
say for, 63:1319 
human menopausal 
ovulation induction with, compared to 
induction by human FSH, 63:1284 
plasma estradiol levels during stimula-
tion with, 63:736 
levels in obese women, 63:1257 
midcycle surge in monkeys, blockade by RU 
486, 63:1270 
output in men, ketoconazole-induced stim-
ulation of, 63:1121 
-producing pituitary adenoma, ^-subunit as 
a tumor marker for, 63:564 
secretion in agonadal men, effect of nalox-
one on, basally or during testosterone 
treatment, 63:257 
secretion in polycystic ovary syndrome, an-
drogen regulation of, 63:215 
serum levels, suppression of by a LHRH 
antagonist, in normal men, 63:303 
Gonadotropin-releasing hormone 
agonist of 
effects in polycystic ovarian disease, 
63:1031 
treatment of hirsutism with, 63:854 
antagonist of, ratio of serum bioactive to 
immunoreactive FSH in normal men 
after treatment with, 63:792 
bio- and immunoactive L H responses to, in 
GnRH-deficient men, 63:143 
-deficient men, bio- and immunoactive L H 
responses to GnRH in, 63:143 
response of GH secretion to, in acromegaly, 
63:167 
Granulosa cells, hormonal regulation of, cy-
tochrome P450scc in, 63:202 
Graves' disease 
hyperthyroid, discordant hypothyroxine-
mia and hypertriiodothyroninemia in 
treated patients with, 63:102 
lack of specificity of ophthalmic immuno-
globulins in, 63:990 
GRF, See Growth hormone-releasing factor 
Growth hormone 
effect of GHRH on secretion of, in normal 
men, 63:1016 
endogenous secretion of, GH provocative 
testing is not reflection of, 63:709 
GHRH-(l-44)-induced secretion of, in 
acromegaly and type I diabetes melli-
tus, effect of cholinergic muscarinic re-
ceptor blockade on, 63:389 
growth response relationship between short 
term growth and dose of, in patients 
with Turner's syndrome, 63:1028 
24-h secretion in children with partial GH 
deficiency, effect of GHRH-(l-44) on, 
63:1100 
-lowering effects of SMS 201-995 and bro-
mocriptine, in acromegaly, 63:16 
partial deficiency, effect of GHRH-Ü-44) 
on 24-h GH secretion in children with, 
63:1100 
plasma levels, effect of obesity on, 63:481 
provocative testing, not reflection of endog-
enous GH secretion, 63:709 
relationship to somatomedin-C levels, in 
acromegaly, 63:1348 
responses to GHRH during pubertal devel-
opment, in normal boys and girls, com-
parison to idiopathic short stature and 
GH deficiency, 63:174 
response to GHRH 
in acromegaly, 63:475 
in men, 63:872 
response to GHRH, TRH, GnRH, and so-
matostatin, in acromegaly, 63:167 
secretion by pituitary tumor cells, insulin-
like growth factor I regulation of, 
63:730 
secretion in postmenopausal women, regu-
lation of, effect of estrogen replace-
ment, 63:424 
single im injection, effects on insulin-like 
growth factors I and I I and their bind-
ing protein after, 63:981 
Growth hormone neurosecretory dysfunction, 
preservation of dopaminergic and a-
adrenergic function in children with, 
63:968 
Growth hormone-releasing hormone 
ectopic production, acromegaly due to, 
63:1057 
effect on GH secretion, in normal men, 
63:1016 
GH and PRL responses to, in acromegaly, 
63:475 
GH responses to, during pubertal develop-
ment, in normal boys and girls, com-
parison to idiopathic short stature and 
GH deficiency, 63:174 
GH response to, in men, 63:872 
infusion in patients with active acromegaly, 
63:88 
localization in human hypothalamus and 
pituitary stalk, 63:47 
plasma levels, relationship to pubertal 
changes, 63:680 
response of GH secretion to, in acromegaly, 
63:167 
Growth hormone-releasing hormone-(l-44) 
effect on 24-h GH secretion, in children 
with partial GH deficiency, 63:1100 
-induced GH secretion, in acromegaly and 
type I diabetes mellitus, effect of cho-
linergic muscarinic receptor blockade 
on, 63:389 
Hashimoto's thyroiditis, monoclonal gam-
mopathy in, 63:1136 
hCG, See Gonadotropin, human chorionic 
Hirsutism 
associated with polycystic ovary syndrome, 
determination of androgen overprod-
uction in, 63:1204 
GnRH agonist treatment of, 63:854 
Howard, John Eager, In Memoriam, 63:272 
16a-Hydroxydehydroepiandrosterone sulfate, 
effect on estrone, 17ß-estradiol, and 
estriol secretion, in human choriocar-
cinoma cells, 63:751 
17-Hydroxylase, activity in adrenal cortex, 
regulation of, 63:613 
21-Hydroxylase, deficiency of, late-onset, 
clinical and biological phenotypes in, 
63:418 
17^-Hydroxysteroid dehydrogenase, activity 
in breast cells, effect of progestin on, 
63:1174 
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3ß-Hydroxysteroid dehydrogenase-isomerase 
deficiency syndrome, new inherited 
variant of, 63:360 
lcY-Hydroxyvitamin D 3 , effect on cell-me-
diated immunity in hemodialyzed pa-
tients, 63:1218 
25-Hydroxyvitamin D, free fraction in serum, 
regulation by albumin and vitamin D-
binding protein, 63:954 
Hypercalcemia, in patients with rhabdomy-
olysis with and without acute renal 
failure, 63:137 
Hyperglycemia, influence on forearm glucose 
uptake and other metabolic responses, 
63:594 
Hyperinsulinemia 
exogenous, effect on proinsulin secretion in 
normal, obese, and insulinoma sub-
jects, 63:1117 
lack of suppression of insulin secretion by, 
in a patient with insulinoma, 63:1411 
Hyperparathyroidism 
intact us. total immunoreactive PTH in, 
clincial implications, 63:447 
primary 
effect of 24,25-dihydroxyvitamin D 3 in, 
63:246 
plasma calcitonin in, 63:785 
secondary, associated with low 1,25-
(OH)2D and normal osteocalcin, in el-
derly subjects, 63:459 
Hyperprolactinemia 
LH responses to opioid and dopamine an-
tagonists in women with pituitary mi-
croadenoma and, 63:1225 
pathological, chronic treatment with ter-
guride, 63:1002 
PRL-lowering effect of cabergoline in pa-
tients with, 63:941 
Hypertension 
contraception using vaginal ring in women 
with, 63:29 
essential 
circulating vascular sensitizing agent in, 
63:463 
effect of sodium balance and calcium 
channel-blocking drugs on plasma al-
dosterone response to angiotensin I I in 
patients with, 63:1126 
plasma atrial natriuretic peptide levels 
in, 63:815 
Hyperthyroidism 
adrenergic regulation of lipolysis in human 
adipocytes in, 63:631 
hypothyroxinemia and hypertriiodothyron-
inemia in treated patients with, 63:102 
treatment with single daily dose of meth-
imazole, 63:125 
Hypocalcemia, in patients with rhabdomy-
olysis with and without acute renal 
failure, 63:137 
Hypoglycemia, tumor-associated, insulin re-
ceptor proliferation as a mechanism 
for, 63:879 
Hypoparathyroidism, altered red cell sodium 
transport in, relation to serum calcium, 
63:626 
Hypophosphatasia, infantile, activity of nu-
cleoside triphosphate pyrophosphatase 
in alkaline phosphatase-deficient f i -
broblasts from patients with, 63:1237 
Hypopituitarism, pubertal growth and final 
height in boys with, role of bone age at 
onset of puberty, 63:376 
Hypothalamus, localization of GHRH in, 
63:47 
Hypothyroidism 
adrenergic regulation of lipolysis in human 
adipocytes in, 63:631 
amiodarone-induced, uninhibited thyroidal 
uptake of radioiodine despite iodine ex-
cess in, 63:485 
amiodarone iodine-induced, potassium Per-
chlorate treatment of, 63:1233 
in patients with high iodine intake, 63:412 
Immunoglobulin 
ophthalmic, in Graves' disease, lack of spec-
ificity of, 63:990 
thyroid growth, in large multinodular en-
demic goiters, effect of iodized oil, 
63:644 
Incretin, effects of increasing glucose loads 
on, 63:492 
Insulin 
antagonism, in amyotrophic lateral scle-
rosis, 63:41 
-dependent diabetes 
antiinsulin receptor antibodies in, 63:56 
decreased ß-adrenergic sensitivity in pa-
tients with, 63:262 
-dependent diabetes mellitus, somatostatin 
analogs and insulin needs in patients 
with, studied by means of artificial 
pancreas, 63:1071 
feedback inhibition of secretion of, in cir-
rhosis, 63:1023 
lack of suppression by hyperinsulinemia of 
secretion of, in a patient with insuli-
noma, 63:1411 
needs in insulin-dependent diabetics, stud-
ied by means of artificial pancreas, 
63:1071 
oscillations, effect on glucose turnover pa-
rameters, in normal subjects, 63:520 
plasma levels, effect of obesity on, 63:481 
sc regular, pharmacokinetics in type I dia-
betic patients, 63:689 
-stimulated glucose utilization, effects of 
ketone bodies on, 63:9 
stimulation of aminoisobutyric acid trans-
port in skin fibroblasts, mediation by 
insulin and type I insulin-like growth 
factor receptors, 63:1181 
systemic delivery rate, 63:113 
venous levels, response to increasing glu-
cose loads, 63:492 
Insulin-like growth factor, autocrine/para-
crine role in regulation of human pla-
cental growth, 63:499 
Insulin-like growth factor-binding protein, ef-
fect of single im injection of GH on, 
63:981 
Insulin-like growth factor I 
effect of single im injection of GH on, 
63:981 
regulation of GH secretion and mRNA lev-
els in pituitary tumor cells, 63:730 
serum levels, in adult diabetics, effect of 
age, 63:651 
Insulin-like growth factor I I 
binding to IM-9 cells, structural and im-
munological characterization of, 
63:1400 
effect of single im injection of GH on, 
63:981 
specific assay for, 63:1151 
Insulin-like growth factor receptor, type I , 
mediation of insulin stimulation of 
aminoisobutyric acid transport in skin 
fibroblasts, 63:1181 
Insulinoma 
effect of exogenous hyperinsulinemia on 
proinsulin secretion in patients with, 
63:1117 
lack of suppression of insulin secretion by 
hyperinsulinemia in a patient wih, 
63:1411 
Insulin receptor 
effects of metformin on, 63:898 
familial disorder with increased number of, 
63:865 
mediation of insulin stimulation of amino-
isobutyric acid transport in skin fibro-
blasts, 63:1181 
proliferation, mechanism for tumor-associ-
ated hypoglycemia, 63:879 
Interferon, thyroid autoimmunity in patients 
receiving therapy with, 63:1086 
Interferon-7, production in autoimmune thy-
roid disease, and thyrocyte HLA-DR 
expression, 63:695 
Iodine 
excess of, uninhibited thyroidal uptake of 
radioiodine despite, in amiodarone-in-
duced hypothyroidism, 63:485 
high intake of, hypothyroidism in patients 
with, 63:412 
Ketoconazole 
-induced reduction in serum l,25-(OH)2D, 
63:766 
-induced stimulation of gonadotropin out-
put in men, 63:1121 
in treatment of Cushing's syndrome, 
63:1365 
mechanism of inhibition of human testicu-
lar steroidogenesis by, 63:1193 
Ketone bodies, effects on basal and insulin-
stimulated glucose utilization, 63:9 
Kidney 
acute renal failure, hypocalcemia and hy-
percalcemia in patients with rhabdorn-
yolysis with, 63:137 
chronic renal failure 
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dexamethasone suppression testing in, 
63:741 
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